Of 149 women recruited and randomized , there were nodifferences between the probiotic and placebo groups in postintervention fasting glucose ( 4.65 0.49 vs 4.65 0.53 mmol/L ; P = 373 ) , requirement for pharmacological therapy ( 17 % vs 14 % ; P = .643 ) , or birthweight ( 3.57 0.64 vs 3.60 0.57 kg ; P = .845 ) .